Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model
Tildipirosin, a 16-membered-ring macrolide antimicrobial, has recently been approved for the treatment of swine respiratory disease and bovine respiratory disease. This macrolide is extensively distributed to the site of respiratory infection followed by slow elimination. Clinical efficacy has been...
Main Authors: | Dongping Zeng, Meizhen Sun, Zhoumeng Lin, Miao Li, Ronette Gehring, Zhenling Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01038/full |
Similar Items
-
Optimal Regimens and Cutoff Evaluation of Tildipirosin Against Pasteurella multocida
by: Zhixin Lei, et al.
Published: (2018-07-01) -
Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model
by: Qingwen Yang, et al.
Published: (2019-09-01) -
Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model
by: Qiaoyi Zhou, et al.
Published: (2017-06-01) -
Pharmacokinetic/pharmacodynamic integration of tilmicosin against Pasteurella multocida in a piglet tissue cage model
by: Yuqin Chen, et al.
Published: (2023-09-01) -
Meningitis bacteriémica por Pasteurella multocida Pasteurella multocida bacteremic meningitis
by: R. Soloaga, et al.
Published: (2008-12-01)